Diagnosing skin malignancy: Assessment of predictive clinical criteria and risk factors

Journal of Family Practice

Volumn 52, Issue 3, 2003, Pages 210-218

  Strayer, Scott M ^a   Reynolds, Peter ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b USAF Clinic   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL CELL CARCINOMA; DEATH; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; HEREDITY; HISTORY; HUMAN; MELANOMA; PHYSICAL EXAMINATION; PHYSICIAN; PRIMARY MEDICAL CARE; PROGNOSIS; REVIEW; RISK FACTOR; SKIN CANCER; SOCIETY; SQUAMOUS CELL CARCINOMA;

BIOPSY; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS; CRITICAL PATHWAYS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MELANOMA; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SKIN NEOPLASMS;

EID: 0037335413     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996; 34:839-847.
2. Skin Tumors. In: Sauer GC, Hall JC, eds. A manual of skin diseases. Philadelphia, Pa: Lippincott-Raven, 1996:342.
3. Landis SH, Murray T, Bolden S, Wingo PA. Cancer Statistics, 1999. CA Cancer J Clin 1999; 49:8-31.
4. Gloster HM, Jr., Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996; 22:217-226.
5. Garner KL, Rodney WM. Basal and squamous cell carcinoma. Prim Care 2000; 27:447-458.
6. Schappert SM, Nelson C. National Ambulatory Medical Care Survey, 1995-96 Summary. Vital Health Stat 1999; 13:1-122.
7. Roetzheim RG, Naazneen P, Van Durme DJ. Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Dermatol 2000; 43:211-218.
8. Jones TP, Boiko PE, Piepkom MW. Skin biopsy indications in primary'care practice: a population-based study. JABFP 1996; 9:397-404.
9. Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MB, Lew RA. Who discovers melanoma: patterns from a population-based survey. J Am Acad Dermatol 1992; 26:914-919.
10. Rowe DE. Comparison of treatment modalities for basal cell carcinoma. Clin Dermatol 1995; 13:617-620.
11. Bruce AJ, Brodland DG. Overview of skin cancer detection and prevention for the primary care physician. Mayo Clin Proc 2000; 75:491-500.
12. Alam M, Ratner D. Primary care: cutaneous squamous-cell carcinoma. N Engl J Med 2001; 344:975-983.
13. Rhodes AR, Weinstock MA, Jr., Fitzpatrick TB, Mihm MC, Jr., Sober AJ. Risk factors for cutaneous melanoma: a practical method of recognizing predisposed individuals. JAMA 1987; 258:3146-3154.
14. Austoker J. Melanoma: prevention and early diagnosis. BMJ 1994; 308:1682-1686.
15. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000; 136:1524-1530.
16. Healsmith MF, Bourke JF, Osborne JE, Graham-Brown RAC. An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous melanoma. Br J Dermatol 1994; 130:48-50.
17. McGovern TW, Litaker MS. Clinical predictors of malignant pigmented lesions: a comparson of the Glasgow seven-point checklist and the American Cancer Society's ABCDs of pigmented lesions. J Dermatol Surg Oncol 1992; 18:22-26.
18. Benelli C, Roscetti E, Dal Pozzo V, Gasparini G, Cavicchini S. The dermoscopic versus the clinical diagnosis of melanoma. Eur J Dermatol 1999; 9:470-476.
19. Thomas L, Tranchand P, Berard F, Secchi T, Colin C, Moulin G. Semiological value of ABCDE criteria in the diagnosis of cutaneous pigmented tumors. Dermatology 1998; 197:11-17.
20. Shaw HM, McCarthy WH. Small-diameter malignant melanoma: a common diagnosis in New South Wales, Australia. J Am Acad Dermatol 1992; 27:679-682.
21. Du Vivier AWP, Williams HC, Brett JV, Higgins EM. How do malignant melanomas present and does this correlate with the seven-point check-list? Clin Exp Dermatol 1991; 16:344-347.
22. Higgins EM, Hall P, Todd P, Murthi R, Du Vivier AWP. The application of the seven-point check-list in the assessment of benign pigmented lesions. Clin Exp Dermatol 1992; 17:313-315.
23. Whited JD, Grichnik JM. Does this patient have a more or a melanoma? JAMA 2002; 279:696-701.
24. Curley RK, Cook MG, Fallowfield ME, Marsden RA. Accuracy in clinically evaluating pigmented lesions. Br Med J 1989; 299:16-18.
25. DeCoste SD, Stern RS. Diagnosis and treatment of nevomelanocytic lesion of the skin: a community-based study. Arch Dermatol 1993; 129:57-62.
26. Grin CM, Kopf AW, Welkovich B, Bart RS, Levenstein MJ. Accuracy in the clinical diagnosis of malignant melanoma. Arch Dermatol 1990; 126:763-766.
27. Koh HK, Caruso A, Gage I, Geller AC, Prout MN, White H et al. Evaluation of melanoma/skin cancer screening in Massachusetts: preliminary results. Cancer 1990; 65:375-379.
28. McMullan FH, Hubener LF. Malignant melanoma: a statistical review of clinical and histological diagnoses. Arch Dermatol 1956; 74:618-619.
29. Cassileth BR, Clark WHJ, Lusk EJ, Frederick BE, Thompson CJ, Walsh WP. How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol 1986; 14:555-560.
30. Gerbert G, Maurer T, Berger T, Pantilat S, McPhee SJ, Wolff M et al. Primary care physicians as gatekeepers in managed care. Arch Dermatol 1996; 132:1030-1038.
31. McGee R, Elwood M, Sneyd MJ, Williams S, Tilyard M. The recognition and management of melanoma and other skin lesions by general practitioners in New Zealand. N Z Med J 1994; 107:287-290.
32. Paine SL, Cockburn J, Noy SM, Marks R. Early detection of skin cancer: knowledge, perceptions, and practices of general practitioners in Victoria. Med J Aust 1994; 161:188-195.
33. Ramsay DL, Fox AB. The ability of primary care physicians to recognize the common dermatoses. Arch Dermatol 1981; 117:620-622.